Telangana COVID-19 vaccine recipient dies; govt says no link to immunisation
All three deaths following immunisation in India attributed to heart attack with no disease history
India in talks with Russia on ‘unverified’ COVID-19 vaccine
Indian serostudies do not talk about neutralising antibodies, says ICMR DG
Coronavirus update: US FDA cautions consumers against toxin in hand sanitisers
India registers highest single-day spike of 66,999 cases August 13; 942 deaths added in 24 hours
Where COVID-19 has left Nigeria’s health system
Doyin Odubanjo, executive secretary of the Nigerian Academy of Science, on how the pandemic may affect the country’s ability to manage …
Phase 1 human trials of Oxford University encouraging: Lancet
The sample size will have to be expanded across demography to check safety and efficacy
Travel post COVID-19: Providing thrust to digital booking
Why e-ticketing introduced in post-globalisation era will be boon in post-COVID-19 one
COVID-19 update: Over 1,000 daily cases in India for first time in 2023
Over 665,000 COVID-19 cases have been reported in the last seven days worldwide, along with 4,178 deaths
COVID-19 Vaccine Watch: Appeals made for support on proposal regarding intellectual property
If it is adopted on December 16, IP rights on production and supply of COVID-19 tools will be waived off
Did Dharavi model work? Is it herd immunity or plain luck?
As cases mounted and the toll rose, the bylanes of Dharavi kept waiting for the system to kick in; for many, the wait never ended
Smoke and mirrors on COVID-19 drugs?
In a brutal fight to corner the successful outcome of research, governments are openly using money power to grab the first rights to promising …
China shifts focus to variant-specific vaccines as it faces an imminent Omicron wave
XBB subvariant has potential to wreak more havoc in China as large number of people immunologically susceptible
India to be 'leading manufacturer' of Russia’s 'doubtful' trial vaccine
Experts caution Indian government against hastened response; Russia researchers claim their vaccine is the best
COVID-19: Did SARS-CoV-2 originate in raccoon dogs from Wuhan wet market? New data gives links
Meanwhile, Israel reports new COVID-19 variant — a combination of BA.1 and BA.2 subvariants of Omicron
How ‘good’ does a COVID-19 vaccine need to be? A new study has answers
A vaccine with an efficacy as low as 60% could still stop the pandemic. However, most, if not all of the population, would have to be vaccinated
Fast COVID-19 vaccine timelines are unrealistic, put integrity of scientists at risk
No vaccine against a coronavirus has successfully navigated the rigours of clinical testing, despite having up to 17 years to do so
COVID-19: Access to devices a must for bridging the digital divide
Most conversations on digital divide revolve around network availability or supply-side factors, but absence of an Internet-enabled handset …
Don’t doubt India’s drug regulator on COVID-19 vaccines: Government
Weekly press meeting also releases details of COVID-19 vaccination; healthcare and frontline workers, seniors to be immunised on priority basis
How ‘vaccine nationalism’ could block vulnerable populations’ access to COVID-19 vaccines
Vaccine nationalism also runs against the fundamental principles of vaccine development and global public health
FAQ on COVID-19 subvariant XBB.1.5: Why is it nicknamed ‘Kraken’?
Answers to questions like what is it, where is it prevalent and how does it differ from Omicron
Coronavirus update: EU leaders reach landmark deal on COVID-19
Serum Institute of India to apply for local trials of Oxford University’s vaccine candidate in India within a week
Bolsanaro’s environmental crimes come under EU scanner
Europe’s resolve to act against the Bolsonaro government’s environmental crimes appears to be strengthening
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached
COVID-19: Why biocide overuse needs to be addressed to tackle AMR
Excessive use of biocides can be a potential threat that could drive AMR further, underlined a WHO editorial
Novel coronavirus detected in sewage in India: Study
However, researchers found no viral genome in treated samples of the sites where the virus was detected in untreated wastewater
Mpox, AIDS & COVID-19 show challenges of targeting public health messaging to specific groups without causing stigma
Racial, sexual stigma around monkeypox spurred World Health Organization to rename the disease to mpox